Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in Alopecia Areata with or without Atopic Dermatitis
NCT03359356Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in alopecia areata, sponsored by Icahn School of Medicine at Mount Sinai. Started Jan 2018; status: completed.
02
Drugs
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT03359356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359356.